卒中的血压管理：五件新事。
Blood pressure management in stroke: Five new things.
作者信息
Bowry Ritvij, Navalkele Digvijaya D, Gonzales Nicole R
机构信息
University of Texas Health Sciences Center at Houston.
出版信息
Neurol Clin Pract. 2014 Oct;4(5):419-426. doi: 10.1212/CPJ.0000000000000085.
Abstract
Hypertension is a major modifiable risk factor for stroke, with an estimated 51% of stroke deaths being attributable to high systolic blood pressure globally. The management of hypertension in stroke is determined by timing, the type of stroke, use of thrombolysis, concurrent medical conditions, and pharmacologic variables. We highlight the details of elevated blood pressure management in the hyperacute/acute, subacute, and chronic stages of ischemic stroke and intracerebral hemorrhage.
摘要
高血压是中风的一个主要可改变风险因素，据估计，全球51%的中风死亡可归因于高收缩压。中风患者高血压的管理取决于时机、中风类型、溶栓药物的使用、并发疾病以及药理学变量。我们重点介绍缺血性中风和脑出血超急性期/急性期、亚急性期和慢性期血压升高管理的细节。
相似文献
1
Blood pressure management in stroke: Five new things.卒中的血压管理：五件新事。
Neurol Clin Pract. 2014 Oct;4(5):419-426. doi: 10.1212/CPJ.0000000000000085.
2
Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR).静脉溶栓治疗缺血性卒中时血压、抗高血压治疗与预后的关系：来自卒中溶栓安全实施-国际卒中溶栓登记研究（SITS-ISTR）的回顾性分析
Stroke. 2009 Jul;40(7):2442-9. doi: 10.1161/STROKEAHA.109.548602. Epub 2009 May 21.
3
Association Between Hyperacute Stage Blood Pressure Variability and Outcome in Patients With Spontaneous Intracerebral Hemorrhage.超急性期血压变异性与自发性脑出血患者预后的关系。
Stroke. 2018 Feb;49(2):348-354. doi: 10.1161/STROKEAHA.117.017701. Epub 2018 Jan 4.
4
Systolic blood pressure after intravenous antihypertensive treatment and clinical outcomes in hyperacute intracerebral hemorrhage: the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study.静脉降压治疗后收缩压与超急性期脑出血临床转归的关系：卒中急性管理中降压治疗的风险因素评估与改善-脑出血研究。
Stroke. 2013 Jul;44(7):1846-51. doi: 10.1161/STROKEAHA.113.001212. Epub 2013 May 23.
5
What are the next breakthroughs in the management of acute intracerebral hemorrhage?急性脑出血管理的下一个突破是什么？
Int J Stroke. 2016 Jun;11(4):386-8. doi: 10.1177/1747493016631559. Epub 2016 Feb 24.
6
Canadian Stroke Best Practice Recommendations: Hyperacute Stroke Care Guidelines, Update 2015.《加拿大卒中最佳实践建议：超急性卒中护理指南，2015年更新》
Int J Stroke. 2015 Aug;10(6):924-40. doi: 10.1111/ijs.12551. Epub 2015 Jul 6.
7
Comparison of blood pressure-associated risk of intracerebral hemorrhage and subarachnoid hemorrhage: Korea Medical Insurance Corporation study.脑出血和蛛网膜下腔出血的血压相关风险比较：韩国医疗保险机构研究
Hypertension. 2005 Aug;46(2):393-7. doi: 10.1161/01.HYP.0000177118.46049.e6. Epub 2005 Jul 5.
8
Baseline blood pressure but not early computed tomography changes predicts major hemorrhage after streptokinase in acute ischemic stroke.急性缺血性卒中患者应用链激酶治疗后，基线血压而非早期计算机断层扫描变化可预测大出血。
Stroke. 2002 Sep;33(9):2236-42. doi: 10.1161/01.str.0000027859.59415.66.
9
Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study.降压与阿替普酶剂量在急性缺血性脑卒中的相互作用：强化高血压控制与溶栓治疗脑卒中研究的结果。
Cerebrovasc Dis. 2019;48(3-6):207-216. doi: 10.1159/000504745. Epub 2019 Dec 6.
10
Blood Pressure Management for Acute Ischemic and Hemorrhagic Stroke: The Evidence.急性缺血性和出血性脑卒中的血压管理：证据。
Semin Respir Crit Care Med. 2017 Dec;38(6):718-725. doi: 10.1055/s-0037-1608777. Epub 2017 Dec 20.
引用本文的文献
1
Sex differences in clinical risk factors in obese ischemic stroke patients with a history of smoking.吸烟史肥胖缺血性脑卒中患者临床危险因素的性别差异。
BMC Cardiovasc Disord. 2024 May 30;24(1):288. doi: 10.1186/s12872-024-03952-6.
2
Sex Differences in Severity and Risk Factors for Ischemic Stroke in Patients With Hyperlipidemia.高脂血症患者缺血性卒中严重程度及危险因素的性别差异
Neurosci Insights. 2024 May 3;19:26331055241246745. doi: 10.1177/26331055241246745. eCollection 2024.
3
Stroke Severity in Ischemic Stroke Patients with a History of Diastolic Blood Pressure Treated in a Telestroke Network.远程卒中网络中接受过舒张压治疗的缺血性卒中患者的卒中严重程度
J Cardiovasc Dev Dis. 2022 Oct 10;9(10):345. doi: 10.3390/jcdd9100345.
4
Molecular mechanisms underlying some major common risk factors of stroke.中风一些主要常见危险因素的分子机制。
Heliyon. 2022 Aug 18;8(8):e10218. doi: 10.1016/j.heliyon.2022.e10218. eCollection 2022 Aug.
5
Effectiveness of patient education in acute stroke: a comparison between a customised computer system and a pictorial information booklet.急性脑卒中患者教育的效果：定制化计算机系统与图片信息手册的比较。
BMJ Health Care Inform. 2020 Aug;27(3). doi: 10.1136/bmjhci-2020-100144.
6
Emergency management of stroke in the era of mechanical thrombectomy.机械取栓时代的卒中急诊管理
Clin Exp Emerg Med. 2019 Dec;6(4):273-287. doi: 10.15441/ceem.18.065. Epub 2019 Dec 31.
7
Towards precision critical care management of blood pressure in hemorrhagic stroke patients using dynamic linear models.采用动态线性模型实现出血性脑卒中患者血压的精准重症监护管理。
PLoS One. 2019 Aug 5;14(8):e0220283. doi: 10.1371/journal.pone.0220283. eCollection 2019.
8
Clinical stroke challenges: A practical approach.临床中风挑战：一种实用方法。
Neurol Clin Pract. 2014 Oct;4(5):376-377. doi: 10.1212/CPJ.0000000000000082.
9
Blood pressure management in stroke: Five new things.卒中的血压管理：五件新事。
Neurol Clin Pract. 2015 Apr;5(2):92. doi: 10.1212/CPJ.0000000000000138.
10
Outcomes of Patients Requiring Blood Pressure Control Before Thrombolysis with tPA for Acute Ischemic Stroke.急性缺血性卒中患者在接受tPA溶栓治疗前需要控制血压的预后情况。
West J Emerg Med. 2015 Dec;16(7):1002-6. doi: 10.5811/westjem.2015.8.27859. Epub 2015 Dec 16.
本文引用的文献
1
Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial.即刻降压对急性缺血性脑卒中患者死亡和主要残疾的影响：CATIS 随机临床试验。
JAMA. 2014 Feb 5;311(5):479-89. doi: 10.1001/jama.2013.282543.
2
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.高风险颅内动脉狭窄患者（SAMMPRIS）强化药物治疗联合或不联合支架置入的疗效：一项随机试验的最终结果。
Lancet. 2014 Jan 25;383(9914):333-41. doi: 10.1016/S0140-6736(13)62038-3. Epub 2013 Oct 26.
3
Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analyses.血压控制与卒中一级预防：近期临床试验数据及荟萃分析概要。
Curr Hypertens Rep. 2013 Dec;15(6):559-74. doi: 10.1007/s11906-013-0401-0.
4
Acute hypertensive response management in patients with acute stroke.急性卒中性高血压的反应管理。
Curr Cardiol Rep. 2013 Dec;15(12):426. doi: 10.1007/s11886-013-0426-7.
5
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke.急性缺血性脑卒中患者静脉内使用组织型纤溶酶原激活物治疗时间与结局。
JAMA. 2013 Jun 19;309(23):2480-8. doi: 10.1001/jama.2013.6959.
6
Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial.近期腔隙性卒中患者的血压目标：SPS3 随机试验。
Lancet. 2013 Aug 10;382(9891):507-15. doi: 10.1016/S0140-6736(13)60852-1. Epub 2013 May 29.
7
Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.急性缺血性脑卒中患者早期管理指南：美国心脏协会/美国卒中协会医疗保健专业人员指南。
Stroke. 2013 Mar;44(3):870-947. doi: 10.1161/STR.0b013e318284056a. Epub 2013 Jan 31.
8
The neuro-critical care management of the endovascular stroke patient.血管内卒中患者的神经重症监护管理。
Curr Treat Options Neurol. 2013 Apr;15(2):113-24. doi: 10.1007/s11940-012-0216-3.
9
Elevated blood pressure management in acute ischemic stroke remains controversial: could this issue be resolved?急性缺血性脑卒中的血压管理仍存在争议：这个问题能否得到解决？
Med Hypotheses. 2013 Jan;80(1):50-2. doi: 10.1016/j.mehy.2012.10.008. Epub 2012 Nov 6.
10
Antihypertensive treatment prolongs tissue plasminogen activator door-to-treatment time: secondary analysis of the INSTINCT trial.抗高血压治疗延长组织型纤溶酶原激活剂治疗时间窗：INSTINCT 试验的二次分析。
Stroke. 2012 Dec;43(12):3392-4. doi: 10.1161/STROKEAHA.112.662684. Epub 2012 Oct 2.
Zotero 插件